Awareness, Screening, and Support: The Female Athlete Triad

Registration


There is no cost to participate. This on-demand course will take approximately 45 minutes to complete. After the assessment, learners will be asked to complete an activity with a passing score of 75%.

Before enrolling in this educational activity, you must log in or create an account. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.
 

Target Audience

Healthcare professionals.

Description

There is a well-documented gap in healthcare providers’ recognition and management of the Female Athlete Triad. Despite growing awareness, many clinicians remain unfamiliar with the current diagnostic criteria, screening tools, and evidence-based management strategies for the Triad. As a result, the condition is often underdiagnosed and/or mismanaged, leading to preventable complications such as stress fractures, infertility, and long-term bone loss. This gap is compounded by limited formal education on the Triad in medical curricula and inconsistent screening practices among providers who work with female athletes.

Clinicians face several barriers in addressing the Female Athlete Triad, including limited awareness and training, time constraints during clinical encounters, and discomfort discussing sensitive topics such as disordered eating or menstrual irregularities. The lack of clear screening guidelines and standardized management protocols also contributes to diagnostic and treatment uncertainty. To overcome these barriers, this educational activity hopes to incorporate evidence-based education focused on early recognition, practical screening strategies, and multidisciplinary care approaches.

Learning Objectives

  1. Describe the pathophysiologic relationship between low energy availability, menstrual dysfunction, and decreased bone mineral density in the Female Athlete Triad and Relative Energy Deficiency in Sport (RED-S).
  2. Recognize clinical indicators and risk factors that place athletes at increased risk for developing the Female Athlete Triad.
  3. Implement evidence-based screening tools and diagnostic criteria to identify the Female Athlete Triad in various clinical settings.
  4. Formulate a coordinated, multidisciplinary management plan that addresses medical, nutritional, and psychological aspects of care for affected athletes.

Speaker

Sydney Jorgensen
Physician Assistant Student, Des Moines University Medicine and Health Sciences

Faculty Advisor

Danielle Horgen, MMS, PA-C
Assistant Professor, Master of Science in Physician Assistant Studies Program, Des Moines University Medicine and Health Sciences

Ms. Horgen has reviewed the slides for completeness, clinical accuracy, and recommended action. 

Terms of Use and Privacy Policy

Recording date: December 19, 2025
Date of original release: December 19, 2025
Most recent review/update: December 19, 2025
Termination date: December 18, 2028

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credits™
  • 0.75 AOA Category 2­B
  • 0.75 CE Contact Hour(s)
Course opens: 
12/19/2025
Course expires: 
12/08/2028
Cost:
$0.00

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.75 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Other Healthcare Professionals: This activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

Disclosures

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Sydney Jordensen - Speaker
  • Danielle Horgen, MMS, PA-C - Faculty Advisor and Content Reviewer

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.

Available Credit

  • 0.75 AMA PRA Category 1 Credits™
  • 0.75 AOA Category 2­B
  • 0.75 CE Contact Hour(s)

Price

Cost:
$0.00
Please login or Create an Account to take this course.